article thumbnail

Comparison Of Rebyota Versus Vowst: A Study Table To Help You Compare Fecal Microbiota Therapies

IDStewardship

Candidate 2025 Mentored by: Christina G. candidate 2025, is a third-year pharmacy student at the University of Iowa College of Pharmacy. In this article a comparison of Rebyota versus Vowst is provided, to help learners differentiate these two fecal microbiota therapies. Authored by: Natalie Boyer, Pharm.D. O’Connor, Pharm.D.,

FDA 324
article thumbnail

Three-year patent strategy for greater medicine access announced

European Pharmaceutical Review

A new strategy for 2023-2025 by the Medicines Patent Pool (MPP) aims to reduce access inequities, by improving the availability and affordability of health products in low- and middle-income countries (LMICs). Part of the plan includes enabling 30 million people to access MPP-licensed products each year by 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top of the 7th for 2023

PQA

Learn more about these opportunities, plus review our progress towards BluePrint PQA 2025 in the newly published PQA Annual Report. PQA Annual Report Today, we published the 2023 PQA Annual Report of Progress Towards Blueprint PQA 2025. Not sure how to get involved? Reach out to us at Engagement@PQAalliance.org for assistance!

article thumbnail

Students Expand Healthcare and Quality Knowledge

PQA

Additionally, I hope to improve my written communication skills to convey concepts, promote collaboration, and contribute to impactful healthcare initiatives. In five years, I envision myself utilizing my skillset as a pharmacist to promote beneficial health outcomes, particularly in underserved communities.

article thumbnail

Five for Friday December 1: Celebrating Success in Advancing Medication Use Quality

PQA

PQA’s strategic plan, Blueprint PQA 2025, includes the vision of achieving organizational excellence through structure and processes that deliver exceptional value to our members and stakeholders. If you have questions, contact us at Communications@PQAalliance.org. Each member organization has one vote.

article thumbnail

Moderna and UK government sign deal to establish mRNA facility

Pharmaceutical Technology

Planned to be operational by 2025, the construction of the facility is anticipated to begin early next year. To back the UK in its international efforts as part of the country’s “100 Days Mission” to lower the future pandemics’ impact, the MITC would offer direct access to pandemic response expertise.

Vaccines 140
article thumbnail

Conference Notebook: ACI’s Cosmetics and Personal Care Products Conference

The FDA Law Blog

MoCRA requires that FDA issue a report on PFAS in cosmetics by the end of 2025, but one takeaway from these discussions was that several states laws create a patchwork of relevant laws, further complicated by a plaintiffs’ bar that is aggressively pursuing class action lawsuits.

FDA 64